Omar H Butt Selected Research

Immune Checkpoint Inhibitors

1/2022

Prolonged response of recurrent IDH-wild-type glioblastoma to laser interstitial thermal therapy with pembrolizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Omar H Butt Research Topics

Disease

8	Alzheimer Disease (Alzheimer's Disease) 04/2023 - 01/2021
6	Neoplasms (Cancer) 09/2023 - 01/2022
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 06/2023 - 01/2022
2	COVID-19 04/2023 - 07/2022
2	Infections 04/2023 - 07/2022
2	Coronary Artery Disease (Coronary Atherosclerosis) 04/2023 - 07/2022
2	Leber Congenital Amaurosis 01/2017 - 12/2014
1	Cicatrix (Scar) 06/2023
1	Down Syndrome (Down's Syndrome) 01/2023
1	cell-associated neurotoxicity 01/2023
1	Central Nervous System Diseases (CNS Diseases) 11/2022
1	Glioma (Gliomas) 05/2022
1	Central Nervous System Neoplasms 01/2022
1	Meningioma (Meningiomas) 01/2022
1	Amyloidosis 01/2022
1	Tauopathies 01/2022
1	Blindness (Hysterical Blindness) 01/2017

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 04/2023 - 01/2021
3	Amyloid (Amyloid Fibrils)IBA 01/2023 - 01/2021
3	Apolipoproteins E (ApoE)IBA 01/2022 - 10/2021
2	CytokinesIBA 04/2023 - 07/2022
2	Proteins (Proteins, Gene)FDA Link 04/2023 - 07/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2021
2	Retinaldehyde (Retinal)IBA 01/2017 - 12/2014
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 06/2023
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2022
1	Methotrexate (Mexate)FDA LinkGeneric 11/2022
1	Vincristine (Oncovin)FDA LinkGeneric 11/2022
1	Temozolomide (Temodar)FDA LinkGeneric 05/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	pembrolizumabIBA 01/2022
1	NucleotidesIBA 01/2022
1	NeurograninIBA 01/2021
1	Synaptosomal-Associated Protein 25IBA 01/2021

Therapy/Procedure

7	Therapeutics 06/2023 - 01/2021
3	Lasers (Laser) 01/2022 - 01/2021
2	Immunotherapy 09/2023 - 01/2022
2	Radiotherapy 11/2022 - 01/2022
1	Aftercare (After-Treatment) 01/2023
1	Chronotherapy 05/2022
1	Precision Medicine 01/2022